文献速递质量管理与危急值

生物安全强化对急诊实验室质量指标的影响:COVID-19大流行的经验

The impact of biosafety enhancement on stat laboratory quality metrics: Lessons from the COVID-19 pandemic.
PubMed 文献 · Clin Chim Acta · 2020-12-04

本研究回顾性比较了2020年3-6月COVID-19高峰期与2019年同期急诊实验室的质量数据,包括周转时间(TAT)和不可接受标本的数量与类型。结果显示2020年3-5月检测量下降而6月略增,TAT相似或略有改善,不可接受标本数量与类型无显著变化,表明大流行挑战下实验室质量指标得以维持。

要点

  • 2020年3-5月检测量较2019年同期下降,6月略增。
  • 2020年TAT与2019年相似或略有改善。
  • 不可接受标本数量与类型在两年间无显著差异。

核心结论

  • 尽管COVID-19大流行对系统造成挑战,急诊实验室质量指标仍得以维持。

研究设计与样本

  • 回顾性研究,比较2020年3-6月与2019年同期的急诊实验室质量数据,包括TAT和不可接受标本数量与类型。

主要发现

  • 2020年3-5月检测量较2019年同期下降,6月检测量较2019年同期略增。
  • 2020年TAT与2019年同期相似或略有改善,归因于采集至接收和接收至审核TAT缩短。
  • 2020年与2019年不可接受标本的数量和类型相似。

临床怎么用

  • 在实施生物安全强化措施时,应监测并维持急诊实验室的TAT和标本可接受性等质量指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: It is unclear if implementation of biosafety action plans in response to the COVID-19 pandemic has affected laboratory quality metrics. METHODS: This retrospective study used quality data, including turnaround time (TAT) and number/type of unacceptable specimens from a stat laboratory supporting an outpatient medical clinic serving predominantly elderly cancer patients. Four months of data from the height of the COVID-19 pandemic (March-June 2020) were compared to the same months in 2019. RESULTS: March-May 2020 test volumes were decreased compared to 2019. June 2020 test volume was slightly increased compared to 2019. TATs in 2020 were similar/ slightly improved compared to the same months in 2019, due to shortened collect to receive and receive to verify TATs. The number and types of unacceptable specimens were similar in 2020 and 2019. CONCLUSIONS: Despite the challenges to the system caused by the pandemic, laboratory quality metrics were maintained.

来源:Clin Chim Acta,查看原文。版权归原作者所有。

引用

  1. Frater JL, Anderson J. The impact of biosafety enhancement on stat laboratory quality metrics: Lessons from the COVID-19 pandemic. Clin Chim Acta. 2020. PMID: 33285119. doi:10.1016/j.cca.2020.11.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。